These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7314312)

  • 1. [Evaluation of the type of tubazid inactivation in nephrotuberculosis with chronic kidney failure].
    Tkachuk VN; Titarenko OT; Vakhmistrova TI; Perova TL
    Urol Nefrol (Mosk); 1981; (6):33-6. PubMed ID: 7314312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of isoniazid in chronic kidney failure].
    Titarenko OT; Vakhmistrova TI; Perova TL; Morozov NV
    Vrach Delo; 1983 Apr; (4):19-22. PubMed ID: 6868525
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dynamics of isoniazid excretion in chronic renal failure].
    Titarenko OT; Vakhmistrova TI; Perova TL
    Probl Tuberk; 1982 Feb; (2):48-52. PubMed ID: 7063480
    [No Abstract]   [Full Text] [Related]  

  • 4. [Concentration of the main antitubercular preparations in the blood serum, urine and renal tissue in renal tuberculosis].
    Tkachuk VN; Miloradovich VM; Vishnevskiĭ BI
    Urol Nefrol (Mosk); 1976; (4):30-3. PubMed ID: 969059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tubazid metabolism in patients with renal tuberculosis].
    Vilenskaia RN; Danilova NK; Kanevskaia SS
    Probl Tuberk; 1972; 50(8):65-8. PubMed ID: 5055504
    [No Abstract]   [Full Text] [Related]  

  • 6. [Qualitative and quantitative difference in the metabolism and inactivation of tubazid, phthivazid and methazid].
    Grebennik LI
    Sov Med; 1968 May; 31(5):47-51. PubMed ID: 5754149
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of plasma levels of isoniazid for dose adjustment in the hemodialysis patients.
    El Kabbaj D; Aatif M; Moussa LA; Khassouani CE; Oualim Z
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):666-7. PubMed ID: 19587514
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of tubazid inactivation in urogenital tuberculosis].
    Sukhodol'skaia AE; Krivosheĭ NF
    Vrach Delo; 1973 Dec; 12():90-3. PubMed ID: 4799106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative value of tubazid, larusan and preparation INKh-17].
    Smirnov GA; Efremova ZR; Galkeeva TN
    Probl Tuberk; 1970; 48(4):29-36. PubMed ID: 5471127
    [No Abstract]   [Full Text] [Related]  

  • 10. [HPLC study of blood isoniazid in patients with tuberculosis in Tunisia: significance and therapeutic results].
    Barhoumi C; Masmoudi AS; Gritli N; Hamza M; Nsiri B; Amor A; Mechghoul S; Belhadj O
    Tunis Med; 1995 Oct; 73(10):379-84. PubMed ID: 9506162
    [No Abstract]   [Full Text] [Related]  

  • 11. [The dynamics of partial renal function in renal tuberculosis during treatment with single daily doses of antitubercular drugs].
    Khachanov RM
    Probl Tuberk; 1971; 49(2):42-5. PubMed ID: 5561918
    [No Abstract]   [Full Text] [Related]  

  • 12. [Laser therapy in renal tuberculosis: mechanism of action].
    Kul'chavenia EV
    Probl Tuberk; 1995; (2):11-3. PubMed ID: 7777451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculostatic activity of the blood and urinary excretion of tubazid in patients with renal tuberculosis].
    Savula MM; Khoma-Lemishko AM
    Probl Tuberk; 1971; 49(8):61-4. PubMed ID: 5152636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemotherapy of renal tuberculosis].
    Mazurek LJ
    Pneumonol Pol; 1985 Jan; 53(1):15-8. PubMed ID: 4011451
    [No Abstract]   [Full Text] [Related]  

  • 15. Optic neuritis and bitemporal hemianopsia associated with isoniazid treatment in end-stage renal failure.
    Kocabay G; Erelel M; Tutkun IT; Ecder T
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1418-9. PubMed ID: 17171829
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biopharmaceutic study of antitubercular agents].
    Pavliuchenkova LP
    Farmatsiia; 1977; 26(4):48. PubMed ID: 902797
    [No Abstract]   [Full Text] [Related]  

  • 17. [Isoniazid levels in the blood, urine and kidney tissue of rabbits with cavernous tuberculosis of a solitary kidney].
    Kochanova NK; Mazaev MB; Tverdokhlebova NG
    Probl Tuberk; 1981 Feb; (2):64-7. PubMed ID: 7243758
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complications of polychemotherapy for renal tuberculosis].
    Kul'chavenia EV; Kuznetsov PV
    Probl Tuberk; 1998; (1):28-30. PubMed ID: 9553430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Features of the side effects of antituberculosis drugs and their prediction in patients with nephrotuberculosis].
    Kazakov KS; Chernik RB; Krivtsova MA
    Probl Tuberk; 1987; (12):33-7. PubMed ID: 3444823
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of inactivation of drugs of the HINA and PAS group on the effectiveness of antibacterial therapy in renal tuberculosis].
    Tkachuk VN; Miloradovich VM; Shenderova RI
    Probl Tuberk; 1976; 3():50-2. PubMed ID: 967858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.